Literature DB >> 33641220

Diuretic response and effects of diuretic omission in ambulatory heart failure patients on chronic low-dose loop diuretic therapy.

Jeroen Dauw1,2, Pieter Martens1, Gregorio Tersalvi1, Joren Schouteden1, Sébastien Deferm1,2, Henri Gruwez1,2, Bart De Moor3,4, Petra Nijst1, Matthias Dupont1, Wilfried Mullens1,4.   

Abstract

AIMS: To study loop diuretic response and effect of loop diuretic omission in ambulatory heart failure (HF) patients on chronic low-dose loop diuretics. METHODS AND
RESULTS: Urine collections were performed on two consecutive days in 40 ambulatory HF patients with 40-80 mg furosemide (day 1 with loop diuretic; day 2 without loop diuretic). Three phases were collected each day: (i) first 6 h; (ii) rest of the day; and (iii) night. On the day of loop diuretic intake, the total natriuresis was 125.9 (86.9-155.0) mmol/24 h and urine output was 1650 (1380-2025) mL/24 h. There was a clear loop diuretic response with a natriuresis of 9.4 (6.7-15.9) mmol/h and a urine output of 117 (83-167) mL/h during the first 6 h, followed by a significant drop in natriuresis and urine output during the rest of the day [2.6 (1.8-4.8) mmol/h and 55 (33-71) mL/h] and night [2.2 (1.6-3.5) mmol/h and 44 (34-73) mL/h]. On day 2, after loop diuretic omission, the natriuresis and urine output remained similarly low the entire day, resulting in a 50% reduction in natriuresis [55.1 (33.5-77.7) mmol/24 h; P < 0.001] and a 31% reduction in urine output [1035 (875-1425) mL/24 h; P < 0.001] compared with the day of loop diuretic intake.
CONCLUSION: Patients with HF on chronic loop diuretic treatment still have a clear diuretic response phase, while loop diuretic omission leads to a significant drop in natriuresis and urine output, arguing against routine cessation of low-dose loop diuretics.
© 2021 European Society of Cardiology.

Entities:  

Keywords:  Diuretic response; Heart failure; Loop diuretics; Natriuresis; Urine output

Year:  2021        PMID: 33641220     DOI: 10.1002/ejhf.2145

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  2 in total

1.  Prognosis of Advanced Heart Failure Patients according to Their Hemodynamic Profile Based on the Modified Forrester Classification.

Authors:  Guillaume Baudry; Juliette Bourdin; Raluca Mocan; Elisabeth Hugon-Vallet; Matteo Pozzi; Antoine Jobbé-Duval; Nicolas Paulo; Patrick Rossignol; Laurent Sebbag; Nicolas Girerd
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

2.  Renal sodium avidity, the prevailing renal target in heart failure.

Authors:  Pieter Martens; W H Wilson Tang; Wilfried Mullens
Journal:  Eur Heart J       Date:  2021-11-14       Impact factor: 35.855

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.